NCT00600249 - "Assessment of the Efficacy of a Neoadjuvant Combination: Chemotherapy-targeted Therapy in Breast Cancer." | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Breast Cancer

Interventions

DRUG

Cetuximab

dosage : 5mg/ml one administration per week: 400 mg/m2 then 250 mg/m2 during 18 weeks

DRUG

Docetaxel

100mg/m2 every 21 days 6 cycles of 21 days

Trial Locations (6)

CHU Albert Michallon, Grenoble

Institut de Cancérologie de la LOIRE, Saint-Priest-en-Jarez

Centre Oscar Lambret, Lille

Centre Jean Perrin, Clermont-Ferrand

Hôpital Georges Pianta, Thonon-les-Bains

Centre Hospitalier, Montluçon